Clinical Trial: A Safety and Pharmacokinetics Study of TL-001 in Healthy Adults and Open-label Assessments in Participants With Ulcerative Colitis

U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07526519) titled 'A Safety and Pharmacokinetics Study of TL-001 in Healthy Adults and Open-label Assessments in Participants With Ulcerative Colitis' on April 06.

Brief Summary: The goal of this study is to evaluate safety, tolerability, pharmacokinetics (PK)), pharmacodynamics (PD) and immunogenicity of single and multiple ascending dose of TL-003 in healthy adult participants.

Study Start Date: April, 2026

Study Type: INTERVENTIONAL

Condition: Healthy Volunteer

Intervention: DRUG: TL-003

Intravenously administered

DRUG: Placebo

Intravenously administered

Recruitment Status: RECRUITING

Sponsor: TrueLab Biopharmaceutical Co., Ltd

Disclai...